Annual report pursuant to Section 13 and 15(d)

Summary of Significant Accounting Policies (Tables)

v3.22.2.2
Summary of Significant Accounting Policies (Tables)
12 Months Ended
Sep. 30, 2022
Accounting Policies [Abstract]  
Schedule of Potentially Dilutive Securities

The following potentially dilutive securities have been excluded from the computation of diluted weighted-average shares of common stock outstanding as they would be anti-dilutive:

 

    2022     2021  
    September 30,  
    2022     2021  
Common stock warrants     2,827,708       2,827,708  
Underwriter warrants     50,416       50,416  
Private warrants     7,549       7,549  
Chanticleer warrants     1,267       1,267  
Series C warrants     809,243       809,243  
Series 3 warrants     276,140        
Unvested restricted stock units     48,156       25,948  
Total anti-dilutive weighted average shares     4,020,479       3,722,131